FREE  DIABETES  WALK,  SCREENINGS TO  BE  HELD  IN  VALLEY, Saturday November 8

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

SATURDAY,  NOV.  8

HARLINGEN – A free “Walk in the Park” Diabetes Walk will be held on Saturday, Nov. 8 at 8 a.m. at McKelvey Park, 1325 S. 77 Sunshine Strip, in Harlingen.  Free blood sugar testing, along with registration, will begin at 7 a.m. that morning. 

Speaker at the event will be Dr. Alfredo Garcia, Endocrinologist.  Participants can choose to walk one, two, or three miles.   T-shirts will be given to the first 400 registered walkers (including children).  Walkers will also receive a free hemoglobin A1c test for diabetes from the Valley Baptist Community Reference Lab.  In addition, there will be free foot screenings by Valley Baptist Wound care; healthy snacks; and face painting.  

- Advertisement -

In addition, participants at the event can ask questions to a doctor with the Valley Baptist Family Practice Residency Program, ask a pharmacist about medications, and / or talk with a dietitian from Aramark Healthcare about healthy eating.  For more information and to register, please call 1-888-902-5433.  Registration will also be available on site the morning of the event.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -